export default function Shlp2OverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        SHLP-2 is a tiny peptide produced inside your mitochondria &mdash; the energy-generating organelles in every cell. It&rsquo;s part of a recently discovered family of signals that mitochondria send out to protect cells, reduce inflammation, and support metabolic health. The biology is genuinely fascinating, but there are no human clinical trials yet. This is deep frontier territory.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Average Person &mdash; Longevity-curious, wants to understand mitochondria</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I keep hearing that mitochondria are the key to aging well &mdash; what is SHLP-2 and why do longevity researchers care about it?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Mitochondria talk to the rest of the body, and SHLP-2 is one of those signals</strong><br />Scientists recently discovered that mitochondria don&rsquo;t just produce energy &mdash; they release small peptides that carry messages to other cells. SHLP-2 is one of these signals, associated with cell protection and metabolic health. Human blood levels of SHLP-2 have been linked to longevity markers in observational studies &mdash; people with higher circulating levels tend to show healthier aging profiles.</li>
          <li><strong>Early signals for cell protection and metabolic support</strong><br />In laboratory studies, SHLP-2 has shown anti-apoptotic effects (protecting cells from dying prematurely) and insulin-sensitizing signals. These are the kinds of mechanisms that matter for healthy aging at the cellular level, which is why the longevity community is watching this class of peptides closely.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Everything known about SHLP-2 in humans comes from observational data &mdash; what naturally circulating levels correlate with &mdash; not from giving people SHLP-2 and watching what happens. There are zero clinical trials. What injecting exogenous SHLP-2 actually does in a living human body is genuinely unknown. The gap between &ldquo;higher natural levels correlate with healthier aging&rdquo; and &ldquo;injecting it does something beneficial&rdquo; is enormous. Net: fascinating science; essentially no human evidence that supplementing with it does anything useful.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; Mitochondrial performance and cellular resilience</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to support mitochondrial function for better energy production and recovery &mdash; does SHLP-2 have any direct performance relevance, or is this purely a longevity play?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Mitochondrial-derived peptides and energy system health</strong><br />Mitochondria are central to athletic performance &mdash; they produce the ATP that powers sustained effort and drive the recovery process between sessions. The idea that mitochondria send protective peptide signals to cope with cellular stress is directly relevant to hard training, where mitochondrial stress is constant and recovery of mitochondrial function determines training adaptation speed.</li>
          <li><strong>Anti-apoptotic signals relevant to muscle tissue preservation</strong><br />SHLP-2&rsquo;s proposed anti-apoptotic effects &mdash; protecting cells from programmed death &mdash; are theoretically interesting for muscle tissue under high training load. Cell death signaling in muscle after intense exercise is a normal part of the adaptation process, but excessive apoptosis (from overtraining or injury) is part of what slows recovery.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Every claimed performance benefit for SHLP-2 is theoretical inference from cellular biology &mdash; there is not a single human performance trial. Exercise itself is one of the strongest known stimuli for mitochondrial biogenesis and healthy mitochondrial signaling. If mitochondrial health is the goal, training hard and recovering well has far more evidence behind it than injecting an uncharacterized peptide. Net: extremely early-stage compound; athletes are better served by mitochondria-targeted approaches with actual evidence.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; Mitochondrial peptide biology and longevity stack design</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;How does SHLP-2 relate to humanin and MOTS-c mechanistically? Does stacking mitochondrial-derived peptides make sense, and what&rsquo;s the honest frontier of this research?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>A genuinely new class of biology &mdash; mitochondrial-encoded peptides</strong><br />SHLP-2 is encoded by mitochondrial DNA in a genomic region (the 16S rRNA gene) that was thought to only make structural RNA. The discovery that this region also encodes bioactive peptides via small open reading frames is a recent paradigm shift in cell biology. SHLP-2 is part of a family of six humanin-like peptides (SHLP-1 through SHLP-6), each with distinct biological profiles. Within the family, SHLP-2 shows some of the strongest anti-apoptotic and insulin-sensitizing signals in early cell studies.</li>
          <li><strong>Mechanistic differentiation from humanin and MOTS-c</strong><br />Humanin (21 amino acids, cytoprotective, neuroprotective) and MOTS-c (16 amino acids, AMPK pathway, exercise mimetic) are the better-known mitochondrial peptides. SHLP-2 (12 amino acids) sits in a different size class and has a distinct profile. For biohackers building a longevity stack, the theoretical rationale for complementary mechanisms across the MDP family has a coherent logic &mdash; just no human trial validation.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Even humanin &mdash; discovered in 2001 and far better studied &mdash; has only very limited human clinical data. SHLP-2 was identified in 2016 and has essentially none. The entire mitochondrial peptide category is preclinical as of early 2026. Sourcing is a genuine problem: there are very few reliable vendors, quality verification is difficult, and peptide identity confirmation requires third-party testing. Stacking multiple uncharacterized peptides multiplies unknown-unknown risk in a way that isn&rsquo;t offset by theoretical synergy. Net: the most intellectually interesting biology in the longevity peptide space; the least evidence for human benefit of anything in the community.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What SHLP-2 is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Clinically validated in any human trial &mdash; zero clinical evidence as of 2026</li>
              <li>Available from pharmaceutical-grade sources &mdash; research peptide vendors only</li>
              <li>A proven longevity intervention &mdash; correlation data from natural levels, not causation from supplementation</li>
              <li>Something with a known safe dose in humans &mdash; completely uncharacterized</li>
              <li>Interchangeable with humanin &mdash; related but distinct biology</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>Part of a genuinely novel class of mitochondrial biology only recently discovered</li>
              <li>Among the strongest anti-apoptotic and insulin-sensitizing signals within the SHLP family in cell studies</li>
              <li>Circulating levels associated with longevity biomarkers in human observational data</li>
              <li>Represents a new frontier in understanding how mitochondria communicate with the body</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
